Common questions about Celectan (FAQ)
Q: Is Celectan a type of antibiotic?
Celectan is officially classified as an Antiprotozoal Agent and belongs to the unique thiazolide chemical class. While it demonstrates broad anti-infective activity against certain protozoa and helminths (worms), its primary authorized uses are for treating specific parasitic infections.
Q: How long does Celectan stay in your system?
According to official product information, the elimination half-life for Celectan’s active component, tizoxanide, is reported to be between 3.5 hours and 7.3 hours. This means that half of the active drug is naturally removed from the body within that time frame.
Q: Can Celectan be prescribed to children?
Yes, Celectan is authorized for use in pediatric patients, but its administration depends on the specific formulation. The oral suspension is authorized for children 1 year of age and older, and the 500 mg tablets are for patients 12 years of age and older.
Q: Can Celectan be used during pregnancy?
Regulatory documents state that there are no available human data on the use of Celectan in pregnant women to determine a drug-associated risk. Studies conducted in animals did not show harm to the fetus at exposures higher than the recommended human dose.
Q: Is Celectan available in different strengths?
Yes, Celectan is supplied in two primary forms: 500 mg tablets and a powder for oral suspension. The suspension form, once mixed with water, provides a concentration of 100 mg per 5 mL.
Q: Is it true that Celectan should not be taken by people with kidney problems?
Official guidance indicates that caution is required for patients who have hepatic (liver) or renal (kidney) impairment. This is because the drug’s processing and elimination pathways may be affected in these conditions, which is an important safety consideration noted in official documents.
Q: Is it normal to feel tired when taking Celectan?
Adverse event reporting for Celectan includes somnolence (sleepiness or drowsiness) among nervous system effects. The frequency of this side effect is not reliably estimated from initial clinical trials.
Q: Are there any foods or drinks I need to avoid while on Celectan?
Regulatory documents state the drug is required to be taken with food to support absorption. Official information does not list specific foods or drinks that must be avoided, although high-fat meals have been observed to slightly reduce the rate of absorption.
Q: Is Celectan the same as [Name of a common similar drug]?
Celectan is the brand name for the active ingredient Nitazoxanide, which is the prototype compound of the unique thiazolide chemical class of anti-infective agents. This unique classification distinguishes it from other common drug classes.
Q: What is the risk of having a serious reaction to Celectan?
Celectan is contraindicated (should not be used) in patients with a prior known hypersensitivity (allergic) reaction to the drug or its ingredients. Official labeling states that if signs of a serious allergic reaction, such as swelling or difficulty breathing, occur, medical attention is warranted.
Q: Can Celectan affect my sleep schedule?
Adverse reaction reporting includes insomnia (difficulty sleeping) among psychiatric effects. Official product documents note that the frequency of this adverse reaction is not reliably estimated from clinical trials.
Q: Is Celectan considered a controlled substance?
No, Celectan (nitazoxanide) is not classified as a controlled substance under the U.S. Controlled Substances Act (CSA).
Q: What is the research evidence for Celectan's effectiveness?
Regulatory sources confirm Celectan is officially indicated for the treatment of diarrhea caused by two specific parasites: Cryptosporidium parvum and Giardia intestinalis. This indication applies to immunocompetent patients 1 year of age and older.
Q: What happens if I miss a dose of Celectan?
Official patient information describes the procedure for a missed dose, which typically involves taking it when remembered, unless it is close to the next scheduled dose. The guidance also includes a statement that a double dose should not be taken to compensate for a missed dose.
Q: Is it okay to stop taking Celectan suddenly?
Official patient information notes the importance of completing the full course of medication as prescribed. This helps ensure effective treatment and clearance of the underlying infection, even if symptoms begin to improve before the course is finished.
Q: Can taking Celectan affect the results of a blood test?
Adverse event reports have included rare instances of changes in lab values, such as increased creatinine and increased ALT. These are markers measured in blood tests for kidney and liver function, respectively.
Q: Why is Celectan sometimes considered a second-line treatment?
For some conditions, Celectan is listed as an alternative drug to other established first-line treatments within clinical treatment guidelines. For other indications (like C. parvum), it is considered a drug of choice.
Q: Is there a generic version of Celectan available?
Yes, the active ingredient in Celectan, nitazoxanide, is available as a generic version.
Q: Does Celectan make you drowsy?
The adverse event list includes somnolence (drowsiness or sleepiness) among nervous system effects. Official product documents note that the frequency of this adverse reaction is not reliably estimated from clinical trials.
Q: How is Celectan different from a placebo in clinical trials?
Regulatory-linked reviews mention that the side effect profile of Celectan in trials for giardiasis did not significantly differ from placebo. This data point contributes to the understanding of the drug’s tolerability.
Q: Why is Celectan sometimes given as a combination therapy?
Studies have investigated Celectan as an add-on therapy in the research setting for chronic conditions such as hepatitis. This demonstrates its potential role as a complementary agent alongside other treatments.
Q: Is Celectan used for short-term or long-term treatment?
The standard FDA-approved regimen for parasitic infections is a short-term, fixed duration of three consecutive days. However, regulatory-linked research has also evaluated long-term use for other conditions in a research setting.
Q: Can Celectan affect my ability to drive or operate machinery?
Adverse reaction reporting includes post-marketing reports of dizziness. Since dizziness is a nervous system effect, it could potentially affect a person's ability to drive or operate machinery safely.
Q: Are there any specific organs Celectan can harm?
Official guidance advises caution in patients with hepatic (liver) or renal (kidney) impairment, indicating that these organ systems are important safety considerations noted in official documents. Adverse event reports have included effects on these systems such as increased liver enzymes.
Q: What is the half-life of Celectan?
According to official product information, the elimination half-life for Celectan’s active component, tizoxanide, is reported to be between 3.5 hours and 7.3 hours.
Q: Does Celectan have a risk of dependence or addiction?
No, Celectan is not classified as a controlled drug under the Controlled Substances Act (CSA). This classification is often used as an indicator of low potential for dependence or addiction.
Q: How does the body break down Celectan?
Celectan is rapidly hydrolyzed (broken down) by the body into its active metabolite, tizoxanide. This metabolite then undergoes further processing before the compounds are eliminated through the urine, bile, and feces.
Q: What information is important to share with my doctor before starting Celectan?
It is important to inform a health professional about any history of an unusual or allergic reaction to the drug, as well as any existing kidney disease, liver disease, or immune system problems. These pre-existing conditions are official safety considerations.
Q: Has Celectan been approved in countries outside the US?
Regulatory-linked research references the drug's availability and use in markets outside of the United States, including countries such as India and Mexico, indicating broader international use.
Q: What should I do if my side effects from Celectan seem to be getting worse?
Official guidance describes the need to report side effects to a healthcare team, especially if signs of an allergic reaction or severe symptoms occur.
